Effect of Helicobacter pylori eradication on patients suffering rosacea: a clinical trial study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015051418946N3

Enrollment

150

Registered

2015-06-29

Start date

2015-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea. Rosacea

Interventions

Intervention group:These patients will undergo a standard two-week course of treatment for H. pylori infection which includes metronidazole 500 mg orally twice a day, clarithromycin 500 mg orally twic

Treatment - Drugs

Eligibility

Sex/Gender

All

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: confirmed H.pylori infection; Suffering Rosacea. Exclusion criteria:patients older than 65 and younger than 20; Existanse of any other dermatologic problem; patients refusal to continue study in any stage of study; allergy to clarithromycin, omeprazole; pregnant or breast-feeding; antibiotic therapy within the past 2 months; topical treatment of rosacea in past 3 weeks

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Duluth Rosacea Scoring Scale. Timepoint: Before eradication- 60 days after study beginning. Method of measurement: Assessing by dermatologist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Parviz Saleh

Emam Reza educational-medical center

p.zzss@yahoo.com+98 41 3337 5411

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026